The present invention relates generally to medical implants, and particularly to breast implants.
A breast implant is either inserted in a human breast or attached on the breast, e.g., in order to replace tissue that has been medically removed in an operation such as a mastectomy, or for cosmetic purposes. The purpose of the breast implant is to restore to the breast its external form, including its tactile feel and weight.
Various technologies were proposed in patent literature to form breast implants. For example, U.S. Pat. No. 5,658,330 describes a breast prosthesis for implantation beneath the skin. In an embodiment, the prosthesis has an outer elastic shell which encloses a biocompatible fluid and a silicone foam insert of unitary construction having the shape and approximate consistency of breast tissue. The foam insert occupies substantially the entire volume enclosed by the shell of the implantable prosthesis and consists of a foam body that is molded to the shape of the breast. The insert is of unitary construction and is made by (a) heating a mold to an appropriate temperature; (b) mixing air bubbles into a dispersion of uncured silicone; (c) injecting the bubble-laden, uncured silicone into the preheated mold; and (d) applying a vacuum until the foam insert cures.
As another example, U.S. Pat. No. 9,339,371 describes a prosthetic implant material for use in a prosthetic implant, comprising a gel and optionally a gas. In an embodiment, the filling material is a mixture of an unrestricted grade of Silicone gel and specially customized hollow glass microspheres filled with a gas.
U.S. Patent Application Publication 2011/0029077 describes a medical implant that includes porous silicon with bubbles of different sizes, and a silicon film enclosing the porous silicon. Also, the medical implant includes porous silicon balls with bubbles and a silicon film enclosing the porous silicon balls. Cushion and weight of the implant can be properly adjusted so as to maintain the cushion at a level similar to that of cellular cells of the human body and to shorten a recovery time. Plural grooves or through-holes are provided on a surface of the implant, and thus body fluid smoothly flows through the grooves or through-holes to improve the affinity of the implant against the cellular cells.
A method for manufacturing a breast implant including producing an elastic filler material including foam, by mixing a carbonate with a hydrolyzed silicone. A flexible shell, configured for implantation within a breast of a human subject, is filled with the elastic filler material.
In some embodiments, the method further includes homogenizing the foam by spinning the foam during or after mixing the hydrolyzed silicone and the carbonate.
In some embodiments, mixing the carbonate includes mixing sodium bicarbonate.
In an embodiment, mixing the carbonate with the hydrolyzed silicone includes mixing the hydrolyzed silicone and the carbonate with a catalyst.
In another embodiment, producing the elastic filler material includes producing a foam of silicone gel mixed with carbon dioxide bubbles.
In some embodiments, producing the elastic filler material includes tuning a hardness of the silicone gel by tuning at least one of a size and a density of the carbon dioxide bubbles.
There is additionally provided, in accordance with an embodiment of the present invention, a breast implant that includes an elastic filler material and a flexible shell. The elastic filler material includes a homogeneous foam of silicone gel mixed with carbon dioxide bubbles. The flexible shell contains the elastic filler material and is configured for implantation within a breast of a human subject.
The present invention will be more fully understood from the following detailed description of the embodiments thereof, taken together with the drawings in which:
A breast implant may contain an elastic filler material, such as silicone gel, which is contained in a sealed flexible shell. A breast implant filled with such a material would be relatively heavy, and may cause discomfort to the wearer of the implant. To reduce the weight of the implant a gas such as air or carbon dioxide may be injected into the gel, to effectively form a foam and/or an emulsion. However, gas injection can be relatively complicated, and a simpler process would be useful.
Embodiments of the present invention that are described hereinafter provide an implantable device that is used as a breast implant. In some embodiments, a foam filling of the implant is produced by chemical reactions. In the description hereinafter foam and/or emulsion are collectively referred to as ‘foam,’ for brevity. For producing the foam, an embodiment the disclosed method uses the fact that the silicone gel is formed by hydrolysis of a silicone monomer, yielding hydrochloric acid (HCl) as a byproduct. A carbonate, such as sodium bicarbonate is added to the hydrolyzed mixture, and the carbonate reacts with the HCl to produce carbon dioxide bubbles (and common salt, NaCl). The mixture, with the bubbles may be spun to even out the bubbles in the gel.
In an embodiment, the implant elasticity is tuned during production by tuning the hardness of the manufactured silicone gel, such that an implant made with the softest silicone gel would weight about 70 percent of that made with the hardest silicone gel. In an embodiment, tuning the hardness of silicone gel is performed by tuning the size and/or density of the gas bubbles created in the gel. The hardness of gel may be determined in the development stage of the gel preparation process, for example by trial and error, and kept the same by a stable manufacturing process.
In some embodiments, an implant is provided, that by using a chemical process to produce the bubbles, comprises a highly homogeneous silicone gel.
The disclosed technique can simplify the formation of light breast implants, for example by eliminating manufacturing steps such as gas injection and sealing steps. Furthermore, the disclosed technique may simplify the manufacturing process of the silicone gel itself, for example, by avoiding additional processes such as the rinsing out the HCl byproduct. Thus, implementing the disclosed technique may increase the availability of light breast implants.
NaHCO3+HCl→NaCl+H2O+CO2(g)
In some embodiments a catalyst may be added to the mixture to speed up the production of the bubbles at step 32 and/or the speed of curing of the resulting silicone-gel.
Finally, at a mixture homogenization step 34, the foam is put on a spinner which spins the mixture so as to even (i.e., homogenize) the spatial distribution of carbon dioxide bubbles in the foam.
In some embodiments, a flexible shell is filled with the filling material produced using the method of
The example flow chart shown in
As noted above, other chemicals may be used for creating the foam, where sodium bicarbonate was presented by way of example. Other manufacturing steps may be included, such as filtration and temperature settings, which for clarity are not shown. The timing of manufacturing steps may vary. For example, spinning of mixture can begin during or before or after production step 32.
Although the embodiments described herein mainly address breast implants, the methods and systems described herein can also be used in other applications, in which an implant comprising silicone-gel needs to be lightweight.
It will thus be appreciated that the embodiments described above are cited by way of example, and that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and sub-combinations of the various features described hereinabove, as well as variations and modifications thereof which would occur to persons skilled in the art upon reading the foregoing description and which are not disclosed in the prior art. Documents incorporated by reference in the present patent application are to be considered an integral part of the application except that to the extent any terms are defined in these incorporated documents in a manner that conflicts with the definitions made explicitly or implicitly in the present specification, only the definitions in the present specification should be considered.
This application claims the benefit of U.S. Provisional Patent Application 62/658,896, filed Apr. 17, 2018, whose disclosure is incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
4599367 | Bauman et al. | Aug 1986 | A |
4767794 | Modic et al. | Aug 1988 | A |
5658330 | Carlisle et al. | Aug 1997 | A |
9339371 | Dvir et al. | May 2016 | B2 |
20100143652 | Stockton | Jun 2010 | A1 |
20100163192 | Medoff | Jul 2010 | A1 |
20110029077 | Choi | Feb 2011 | A1 |
20110184530 | Datta | Jul 2011 | A1 |
20130289235 | Daniloff | Oct 2013 | A1 |
20180280131 | Schuessler | Oct 2018 | A1 |
20190314144 | Govari | Oct 2019 | A1 |
20200078490 | Leimer | Mar 2020 | A1 |
20200100893 | Kihara | Apr 2020 | A1 |
20200113671 | Algawi | Apr 2020 | A1 |
20200129286 | Algawi | Apr 2020 | A1 |
Number | Date | Country |
---|---|---|
2550942 | Jan 2013 | EP |
2014039414 | Mar 2014 | WO |
2016108228 | Jul 2016 | WO |
Entry |
---|
EP Search Report—EP 19169454 dated Sep. 18, 2019. |
Number | Date | Country | |
---|---|---|---|
20190314144 A1 | Oct 2019 | US |
Number | Date | Country | |
---|---|---|---|
62658896 | Apr 2018 | US |